← Leaderboards
Jeffrey Y Wong
Beckman Research Institute/City Of Hope
$4,970,582
Attributed
$9,164,109
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,164,109 · 8
By mechanism
R01$6,952,265 · 4
P01$1,405,006 · 2
R21$806,838 · 2
Top collaborators
- Susanta K Hui5 shared
- John E. Shively4 shared
- Stephen J Forma3 shared
- Anthony Stein3 shared
- Paul Yazaki3 shared
- David Morris Colcher2 shared
- Eileen Smith2 shared
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Susanta K Hui$5,584,345
- Robert Wi Chen$1,186,185
- Marcin Kortylewski$7,220,327
- Anthony Stein$260,950
- Eileen Smith$127,212
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorDoseToxic EffectRadiationClinical TrialsSiteDesignRegimenOrganResponseAreaImageTissuesRadiation TherapyPublishingAntibodiesDosimetrySurvival RateTransplantation ConditioningConditioningRelapseRefractorySafetyEnvironment
Grant awards (27)
Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia$738,698
R01 · FY2025 · CA · contact PI
Targeted radiation and immunocytokine therapy for CEA positive malignancies$676,263
R01 · FY2025 · CA
Conformal Total Body and Marrow Irradiation for Leukemia$657,603
R01 · FY2024 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies$642,450
R01 · FY2024 · CA
Conformal Total Body and Marrow Irradiation for Leukemia$677,328
R01 · FY2023 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies$676,263
R01 · FY2023 · CA
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia$192,024
R21 · FY2023 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$687,213
R01 · FY2022 · CA
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia$233,179
R21 · FY2022 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$705,084
R01 · FY2021 · CA
Conformal Total Body and Marrow Irradiation for Leukemia$708,512
R01 · FY2020 · CA
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$238,425
R01 · FY2018 · CA
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$272,213
R01 · FY2017 · CA
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$272,213
R01 · FY2016 · CA
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM$174,122
R21 · FY2016 · CA
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM$207,513
R21 · FY2015 · CA
RADIOIMMUNOTHERAPY: CLINICAL STUDIES$140,555
P01 · FY2011 · CA · contact PI
RADIOIMMUNOTHERAPY: CLINICAL STUDIES$245,900
P01 · FY2010 · CA · contact PI
RADIOIMMUNOTHERAPY: CLINICAL STUDIES$241,076
P01 · FY2009 · CA · contact PI
RADIOIMMUNOTHERAPY: CLINICAL STUDIES$233,953
P01 · FY2008 · CA · contact PI
RADIOIMMUNOTHERAPY: CLINICAL STUDIES$230,528
P01 · FY2007 · CA · contact PI
CORE--ANALYTICAL AND ANIMAL$0
P01 · FY2002 · CA
Radioimmunotherapy$0
P01 · FY2002 · CA
CORE--ANALYTICAL AND ANIMAL$0
P01 · FY2001 · CA
HUMAN STUDIES$0
P01 · FY2001 · CA
CORE--ANALYTICAL AND ANIMAL$156,497
P01 · FY2000 · CA
HUMAN STUDIES$156,497
P01 · FY2000 · CA